EcoDrugPlus

Fatty Acid Amide Hydrolase

Ensembl ID : ENSUMAG00000023571
Gene Symbol: FAAH
4 Cross references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSUMAG00000012025
Gene Symbol: FAP
4 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSUMAG00000004611
Gene Symbol: FGF2
1 Cross references
117 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSUMAG00000009245
Gene Symbol: FGFR1
4 Cross references
289 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSUMAG00000004111
Gene Symbol: FGFR2
3 Cross references
211 Possible Orthologues:

Fibroblast Growth Factor Receptor 4

Ensembl ID : ENSUMAG00000024347
Gene Symbol: FGFR4
4 Cross references
123 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSUMAG00000016979
Gene Symbol: FLT3
4 Cross references
133 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSUMAG00000024583
Gene Symbol: FLT4
4 Cross references
195 Possible Orthologues:

Folate Hydrolase 1

Ensembl ID : ENSUMAG00000024123
Gene Symbol: FOLH1
4 Cross references
210 Possible Orthologues:

Folate Receptor Alpha

Ensembl ID : ENSUMAG00000007838
Gene Symbol: FOLR1
4 Cross references
216 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSUMAG00000013633
Gene Symbol: FSHR
4 Cross references
199 Possible Orthologues:

Free Fatty Acid Receptor 1

Ensembl ID : ENSUMAG00000018472
Gene Symbol: FFAR1
4 Cross references
138 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).